Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZeneca
来源：Barrons发布于 2026-08-03
The merger would be one of the biggest pharma deals ever. AstraZeneca's market capitalization stood at $264 billion as of Friday's close, while Bristol Myers Squibb had a total valuation of $133 billi...
本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。